ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,041 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaselPharmaMar AG
PharmaMar AG Logo
Verified· 2 sources

PharmaMar AG

Summary

About the company

The core activity of PharmaMar is the development and marketing of cancer drugs, particularly marine-derived oncology therapies. The company researches and develops innovative treatments for cancer patients and offers products such as Yondelis, Zepzelca and Aplidin.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered3
Oncologic medicines
Oncologic medicines with marine derivatives, including Yondelis®, Zepzelca® and Aplidin®; information for healthcare professionals as well as patient and product support.
Pharmacovigilance
Pharmacovigilance for reporting side effects and adverse events; reporting via form, e-mail or telephone as well as information on medicine safety.
Strategic partnerships and licensing
Strategic partnerships, licensing and acquisition for oncological projects; collaboration with local companies for development and marketing outside Europe.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Comparisons

PharmaMar AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank PharmaMar AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of PharmaMar AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Aeschengraben 29
4051 Basel

At a glance

Legal form
Corporation
UID
CHE-109.390.564
Founded
2001 · 25 years
Last commercial register change
June 8, 2026
Employees
11 to 20

Knowledge

No knowledge articles yet

Once PharmaMar AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

GS
Genevant Sciences GmbH
Basel
DA
Drossapharm AG
Basel
LP
Luye Pharma Switzerland AG
Basel
LP
Luye Pharma Europe AG
Basel
US
Urovant Sciences GmbH
Basel
UE
Ultragenyx Europe GmbH
Basel
RP
Rhizen Pharmaceuticals AG
Basel
TP
Tanimswiss Pharma GmbH
Basel